AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,587 | -12.6% | 751 | 0.0% | 0.00% | – |
| Q2 2023 | $21,268 | +193245.5% | 751 | +54.8% | 0.00% | – |
| Q1 2023 | $11 | -78.0% | 485 | -72.8% | 0.00% | – |
| Q4 2022 | $50 | -99.9% | 1,785 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | +25.6% | 1,785 | +2.6% | 0.00% | – |
| Q2 2022 | $39,000 | +200.0% | 1,740 | +295.5% | 0.00% | – |
| Q1 2022 | $13,000 | -75.5% | 440 | -74.3% | 0.00% | – |
| Q4 2021 | $53,000 | -59.5% | 1,710 | -39.6% | 0.00% | -100.0% |
| Q3 2021 | $131,000 | -16.0% | 2,830 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $156,000 | +7.6% | 2,830 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $145,000 | +457.7% | 2,800 | +366.7% | 0.00% | – |
| Q4 2020 | $26,000 | -69.8% | 600 | -75.6% | 0.00% | -100.0% |
| Q3 2020 | $86,000 | +168.8% | 2,458 | +309.7% | 0.00% | – |
| Q2 2020 | $32,000 | +52.4% | 600 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | -90.2% | 600 | -87.1% | 0.00% | -100.0% |
| Q4 2018 | $214,000 | -40.2% | 4,642 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $358,000 | +4375.0% | 4,642 | +2221.0% | 0.00% | – |
| Q1 2016 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |